In patients with PD and Lewy body dementia, nilotinib affects CSF miRNAs that control autophagy and cellular transport genes, including synaptosome associated protein 25 (SNAP25) and vacuolar protein sorting (VPS).10 The gene discussed is SNAP25; the disease is Parkinson disease.